Are elevated levels of Hs-cTnT (>14 ng/L) associated with increased risks of adverse cardiac events in patients with stable CAD?
Elevated high-sensitivity troponin T (>14 ng/L) is a significant prognostic marker for adverse outcomes, including mortality and heart failure, in patients with stable coronary artery disease.
BACKGROUND: High-sensitivity cardiac troponins (Hs-cTns) are reliable indicators of myocardial injury, but their relationship with cardiovascular outcomes remains less understood. This study explores the association between adverse cardiac events and Hs-cTnT levels exceeding 14 ng/L in patients with stable CAD. METHODS: statistics, and both qualitative assessment (Newcastle-Ottawa Scale) and quantitative analysis (Egger's and Beggs test, funnel plots) were conducted. RESULTS: = 0.03). CONCLUSION: Elevated levels of Hs-cTnT (>14 ng/L) are significantly associated with increased risks of RDHF and ACM in patients with stable CAD. Further large-scale prospective studies are warranted to refine risk assessment strategies and mitigate cardiovascular mortality in this population.
Desai et al. (Thu,) studied this question.